123 related articles for article (PubMed ID: 12806792)
21. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
Parker W; Patrocinio H
Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
[TBL] [Abstract][Full Text] [Related]
22. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects.
Finger PT
Surv Ophthalmol; 2009; 54(5):545-68. PubMed ID: 19682622
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiosurgery for childhood arteriovenous malformations.
Fuss M; Salter BJ; Caron JL; Vollmer DG; Herman TS
Acta Neurochir (Wien); 2005 Nov; 147(11):1141-9; discussion 1149-50. PubMed ID: 16021387
[TBL] [Abstract][Full Text] [Related]
24. Application of intensity-modulated radiation therapy for pediatric malignancies.
Peñagarícano JA; Papanikolaou N; Yan Y; Ratanatharathorn V
Med Dosim; 2004; 29(4):247-53. PubMed ID: 15528065
[TBL] [Abstract][Full Text] [Related]
25. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
27. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
Aneja S; Yu JB
Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
[TBL] [Abstract][Full Text] [Related]
28. [Perspectives in biological modulation of radiotherapy].
Deutsch E; Huguet F
Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
30. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
31. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
32. [Intensity modulated radiotherapy (IMRT) in France: The boost of the national funding for the new expensive innovative technologies (STIC 2001 and 2002)].
Marchal C; Bensadoun RJ; Haslé E; Lapeyre M; Carrere MO; Gérard JP
Cancer Radiother; 2003 Nov; 7 Suppl 1():44s-48s. PubMed ID: 15124543
[TBL] [Abstract][Full Text] [Related]
33. Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities.
Fuss M; Shi C; Papanikolaou N
Acta Oncol; 2006; 45(7):953-60. PubMed ID: 16982563
[TBL] [Abstract][Full Text] [Related]
34. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
35. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".
Williamson JF; Dunscombe PB; Sharpe MB; Thomadsen BR; Purdy JA; Deye JA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S2-12. PubMed ID: 18406928
[TBL] [Abstract][Full Text] [Related]
36. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Viola A; Major T; Julow J
Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
[TBL] [Abstract][Full Text] [Related]
37. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
38. Current developments in radiotherapy for paediatric brain tumours.
Taylor RE
Eur J Paediatr Neurol; 2006 Jul; 10(4):167-75. PubMed ID: 16954052
[TBL] [Abstract][Full Text] [Related]
39. Early experience of tomotherapy-based intensity-modulated radiotherapy for breast cancer treatment.
O'Donnell H; Cooke K; Walsh N; Plowman PN
Clin Oncol (R Coll Radiol); 2009 May; 21(4):294-301. PubMed ID: 19249194
[TBL] [Abstract][Full Text] [Related]
40. The clinical application of intensity-modulated radiation therapy.
Ten Haken RK; Lawrence TS
Semin Radiat Oncol; 2006 Oct; 16(4):224-31. PubMed ID: 17010905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
